The Stem Cell Research Enhancement Act Passes the House!

The U.S. House of Representatives just passed the Stem Cell Research Enhancement Act (H.R. 3) by a vote of 253-174 (the vote on last year's bill for H.R. 810 was 238-194).  Prior to voting for H.R. 3, the House defeated a motion that would have placed severe restrictions on institutions where somatic cell nuclear transfer research takes place.  That motion failed by a vote of 189-238.

The American Diabetes Association supports the use of stem cell research in biomedical research, provided such use is consistent with federal guidelines relating to the bioethics for their use. Scientists from across the United States and throughout the world including those at ADA believe that stem cell research, especially embryonic stem cell research, holds great promise in the search for a cure and better treatments for diabetes.

Many thanks to you for raising your voice in support of the Stem Cell Research Enhancement Act!  We expect the Senate will be taking up their bill (S. 5) in the next few weeks.  We will keep you posted.